Salk researchers say certain B cells can find tumors and call in T cells — an early, discovery‑stage finding that could widen immunotherapy options for solid cancers.

San Francisco’s Parker Institute is reorganizing to move more research toward companies and patients, adding senior marketing and communications hires under CEO Karen Knudsen.

Instagram will stop supporting end-to-end encrypted DMs on May 8, 2026. Users with encrypted chats should download important messages and media now.

NASA Administrator Jared Isaacman told Michoud workers a Moon base and nuclear‑powered spacecraft could be built in New Orleans as production and hiring ramp up.

A $13M state award will expand Texas A&M’s Cyclotron Institute, boosting radiation testing used by satellites, defense systems and semiconductor makers.

New seafloor analysis finds 'doublet' sediment layers that may mean Cascadia quakes can trigger the San Andreas, raising the risk of back‑to‑back disasters along the West Coast. Researchers point to evidence tied to several past events, including the 1700 megathrust quake.

Rave says Apple removed its co‑watching app after launching SharePlay and has sued in the U.S. and abroad, asking courts to restore the app on iOS/macOS and seek damages. The filing lands amid renewed legal pressure on Apple’s App Store rules.

FAU paired in‑car sensors with quarterly cognitive testing and found that combined driving behaviors — throttle variability, shorter trips and speed control — may flag early cognitive decline.

GBI Biomanufacturing doubled its stem‑cell output in Plantation with a $26M expansion as Florida's 2025 law opens a treatment pathway — but regulators and doctors warn oversight is still unclear.

Milestone Technologies will stop work at Meta’s New Albany data‑center campus, filing WARN notices that put about 105 jobs at risk. The company says its contract at the site is ending.

Roche will acquire Boston-based PathAI for $750M up front, with up to $300M in milestone payments. The deal is expected to close in the second half of 2026 and will fold PathAI into Roche Diagnostics.

Mounjaro's Q1 sales topped Keytruda, lifting Lilly's revenue and reshaping the blockbuster drug ranking.

Moderna, Praxis and other Massachusetts firms joined a new national alliance pushing a Vision 2030 plan to keep U.S. biotech competitive with China.